D268-0326 Screening compound: 2-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1H-1,3-benzodiazol-1-yl]-N-(3-chloro-4-fluorophenyl)acetamide

D268-0326 Screening compound: 2-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1H-1,3-benzodiazol-1-yl]-N-(3-chloro-4-fluorophenyl)acetamide
D268-0326 Screening compound: 2-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1H-1,3-benzodiazol-1-yl]-N-(3-chloro-4-fluorophenyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D268-0326
2-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1H-1,3-benzodiazol-1-yl]-N-(3-chloro-4-fluorophenyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D268-0326

Molecular Formula

C17H12ClFN6O2 (C17 H12 ClFN6 O2)

Compound Name

2-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1H-1,3-benzodiazol-1-yl]-N-(3-chloro-4-fluorophenyl)acetamide

IUPAC name

2-[2-(4-amino-125-oxadiazol-3-yl)-1H-13-benzodiazol-1-yl]-N-(3-chloro-4-fluorophenyl)acetamide

SMILES

Nc1nonc1-c1nc(cccc2)c2n1CC(Nc(cc1)cc(Cl)c1F)=O

InChI

InChI=1S/C17H12ClFN6O2/c18-10-7-9(5-6-11(10)19)21-14(26)8-25-13-4-2-1-3-12(13)22-17(25)15-16(20)24-27-23-15/h1-7H,8H2,(H2,20,24)(H,21,26)

InChI Key

TZLIWLOOSNBFLW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD03133619

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

386.77

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.917

Distribution Coefficient, logD

3.898

Water Solubility, LogSw

-4.32

Polar Surface Area

90.130

Acid Dissociation Constant (pKa)

8.75

Base Dissociation Constant (pKb)

3.96

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

5.90

D268-0326 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

PI3K-Targeted Library (17255 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with D268-0326 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D268-0326?
Check Price and Availability of D268-0326, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D268-0326 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D268-0326
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D268-0326
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D268-0326 available by request